The association of IL-17 (chosen as a surrogate of the second cluster) with ICU survival persisted (adjusted odds ratio of 0.33, 95% CI 0.17–0.66, p < 0.001) after adjustment on patient’s severity (using SAPS II score at ICU admission), organ failures (using SOFA score at septic shock onset) and IL-15 concentration (chosen as a surrogate of the first cluster to reflect innate immunity) (see Additional file 1: Table S4). This evidence concerns the gene IL17A and septic shock.